A common challenge faced pharmaceutical industry analysts, pharmacists, and other healthcare professionals is obtaining objective information on recently approved drugs. […]
DrugChatter adds coverage of recently approved drugs Read Post »
This guest post is from the BiotechBlog Intern, Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin
The Developing World’s Agricultural Biotech Potential: An Asian-African Snapshot Read Post »
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Legal and regulatory update
Go to paperABSTRACT: The European Commission has launched a public consultation on its proposed amendments to the Medical Devic…
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s
Supreme Court Both Invalidates & Upholds Myriad Patents Read Post »
The Nasonex Drug Ad analysis at DrugChatter.com is pretty close to even, with 40/60 split between people not liking and
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
The evolving concept of value add in university commercialisation
Go to paperABSTRACT: Universities have been challenged to assess what value creation mean…
The evolving concept of value add in university commercialisation Read Post »
I have just launched DrugChatter.com. DrugChatter mines the social internet and taps into the DrugPatentWatch database to bring you public opinions
Introducing DrugChatter — Analyzing public opinion on popular drugs Read Post »
This guest post is from the BiotechBlog Intern, Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin
Association for Molecular Pathology v Myriad: Attorneys React Read Post »
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Strategies for improving communication between scientists and the public
Go to paperABSTRACT: It is believed that a scientifically literate society benefit…
Strategies for improving communication between scientists and the public Read Post »
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Singapore’s biomedical science sector development strategy: Is it sustainable?
Go to paperABSTRACT: This paper outlines the strategic efforts undertaken by…
Singapore's biomedical science sector development strategy: Is it sustainable? Read Post »